TrialSupportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer2016

Efficacy benefit of an NK1 receptor antagonist (NK1RA) in patients receiving carboplatin: supportive evidence with NEPA (a fixed combination of the NK1 RA, netupitant, and palonosetron) and aprepitant regimens.

Karin Jordan et al.PubMed ↗Publisher ↗

No numbers read from the abstract.